30 results
8-K
EX-99.1
MKULQ
Molekule Group, Inc.
16 Aug 23
Molekule Reports Second Quarter 2023 Financial Results
7:15am
, healthcare and B2B. Through our commitment to research and innovation, we have developed cutting-edge technologies and rigorous quality standards
424B3
b88cq1xpjsaeqq ah
20 Dec 22
Prospectus supplement
7:34pm
S-4
1zejccha6
19 Dec 22
Registration of securities issued in business combination transactions
11:54am
DRS
ugkheb dt4m
9 Nov 22
Draft registration statement
12:00am
425
y96zhfhe
4 Oct 22
Business combination disclosure
6:14am
425
yy5kupjqnd1tnvxxgdc6
4 Oct 22
Business combination disclosure
6:11am
425
EX-3.2
u6el8
4 Oct 22
Business combination disclosure
6:10am
425
EX-99.1
xr37k20savs
4 Oct 22
Business combination disclosure
6:10am
425
EX-10.3
3m3jdy 8543m5fg
4 Oct 22
Business combination disclosure
6:10am
425
EX-2.1
a3e7oyqem15dlqa
4 Oct 22
Business combination disclosure
6:10am
8-K
EX-2.1
93vlh2dcrn4 f4593
4 Oct 22
Entry into a Material Definitive Agreement
6:08am
8-K
EX-3.2
zfcy3fx8 lc
4 Oct 22
Entry into a Material Definitive Agreement
6:08am
8-K
EX-99.1
07y3328vg34qa
4 Oct 22
Entry into a Material Definitive Agreement
6:08am
8-K
EX-10.3
tkx67 zpny6
4 Oct 22
Entry into a Material Definitive Agreement
6:08am